Protara Therapeutics Inc is trading 5.1% up at $3.83 today as the company holds its Annual General Meeting, drawing investor attention despite a lack of new fundamental disclosures.
- The stock is staging a recovery bounce following several consecutive down sessions, modestly outperforming broader market indices.
- In the absence of fresh price-moving news, the current strength appears to be driven by event-related interest and a general shift toward risk-on sentiment.